(umm, what's up with the warrants) new Reuters report on Cancer Vaccine Partnership Deals lists ADXS
Google "Cancer Vaccine Partnering Agreements Reuters" - released yesterday and includes Advaxis.
Cost $1800, though, so I ain't gettin' a copy anytime soon.
ADXS probably in there for the FusionVax deal?
We had a few baggies like darkplunder who were pumping the warrants and got a little carried away. The warrants are still priced very nicely and are indicating good things are coming shortly to this stock.
So let me get this straight larsondaviss. On October 22nd with the warrants trading at $1.00 you were preaching the value was only .60-.80 cents. I pointed out the warrants were undervalued. The stock proceeded to fall .60 cents over the next month but the warrants only went down .02 cents to .98 (hence they were not overvalued but undervalued on the 22nd).. Since then we have hit a high of 1.98 and are at 1.80 today, an 80% gain from the day we spoke. So again I'll offer up a portion of my profit if it would allow you to buy a clue. Your constant drivel is making everyone around here dumber.
Only 4,000 Warrants traded. While ADXS is no longer a thinly traded stock (last few light volume days not withstanding), the warrants will swing wildly on very low volume. No idea about the Reuters report you mentioned.